report archive

2006 ADA Report
The report Alcohol, Drug and Tobacco Use in Missouri:  A Profile in Prevention and Treatment - 2006 provides data that illustrates the prevalence of – and trends in – alcohol, drug and tobacco use and abuse in Missouri.  When possible, Missouri data are compared to national prevalences and trends.  Additionally, this report presents data on the costs and consequences of substance use and abuse in Missouri. NOTE: If you wish to print this document, change your settings to be in landscape orientation and double-sided printing.

Methamphetamine in Missouri 2004
Methamphetamine in Missouri 2004 was prepared by the Missouri Institute of Mental Health under the direction of the Division of Alcohol and Drug Abuse. The brief describes methamphetamine manufacturing and trafficking, physiological reactions, and health consequences associated with its use. It also includes both state and national epidemiological data describing the prevalence of methamphetamine use as reported by the Community Epidemiology Work Group.

MDMA in Missouri
This policy brief discusses the history of methylenedioxymethamphetamine (MDMA), often referred to as Ecstasy, its relationship to other drugs, its manufacturing and trafficking, and the physiological reactions and health consequences associated with its use. A review of national and Missouri epidemiological data describes the prevalence and patterns of its use. Recommendations for treatment, prevention, and policy are also discussed. Finally, resources for additional study are provided.

OxyContin in Missouri
The purpose of this policy brief is to describe what is currently known about OxyContin, report available national and local data on OxyContin abuse, and present ideas for effective prevention and treatment of OxyContin abuse in Missouri. Some of the communities experiencing significant problems with OxyContin, such as Hazard, Kentucky, and Pulaski, Virginia, are similar in demographic and geographic terms to Missouri communities. Also, there is some evidence that abuse of OxyContin is becoming a trend in America's heartland. For these reasons, it is important that Missouri examine the prevention and interdiction models developed by neighboring states and respond proactively to this emerging problem.

Missouri Prevention Needs Assessment
The Department of Mental Health, Division of Alcohol and Drug Abuse, under the direction of the Center for Substance Abuse Prevention (CSAP), conducted a formal assessment of Missouri's prevention needs. The Prevention Needs Assessment consisted of four research-based studies, each with specific a focus and objective. The purpose of the studies was to provide a framework of data and procedures to inform planning decisions. The data will assist prevention planners and policy makers with identifying high-risk populations, justifying the approaches selected, and assessing the effectiveness of those efforts.